Euphrasia officinalis (Eyebright) extract 1.3 mL
derived from herb dry 650 mg
Solidago virgaurea (Golden Rod) extract 1.3 mL
derived from herb dry 650 mg
Echinacea purpurea (Echinacea) extract 740 µL
derived from root dry 370 mg
Hydrastis canadensis (Golden Seal) extract 69.5 mg
derived from root & rhizome dry 125 mg
Capsicum annuum (Cayenne) extract 30 µL
derived from fruit dry 10 mg
• Do not use if pregnant or likely to become pregnant.
• The risk of allergic reaction to Echinacea is very small, especially if preparations of the root are used since these are free of pollens.
• Echinacea is contraindicated for long-term use in patients taking immunosuppressant medication (e.g. transplant patients) - short-term therapy only is suggested in this instance.
• Caution is advised in patients receiving midazolam by injection.
• Caution in those taking theophylline as Cayenne may increase its absorption and bioavailability.
• Children under two years of age should not be treated for symptoms of respiratory tract infections without medical advice.
• Discontinue 7 days prior to general anaesthesia.
If patient symptoms persist, seek additional professional advice.